FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
WEDNESDAY, May 31, 2023 (HealthDay News) – Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they’re getting the medication, the U.S. Food and Drug Administration warned Tuesday. Shortages of the drug, commonly sold as Wegovy and Ozempic, has led to the making ofContinue Reading